eve Conference Variant Block
* Understanding the current industrial development trend in Asia and the rest of the world
* Optimizing the internal resources and outsourcing partnership within and outside China
* Finding opportunities in China’s rapidly developing preclinical and clinical sectors
* Exploring China’s advantages in cost, talent pool and infrastructure support
* Developing new drug discovery models to drive R&D productivity
* Cultivating a sustainable pipeline of research commercialization and spin- offs in China
* Learning successful experiment from the best practices by top CRO companies
* Networking with key industry professionals from more than 200 international
leading CROs
Package Plan
Before 29/2/2012: USD 440
After 29/2/2012: USD 540
eve Conference Detail Testimonial
Chinese companies and academics reaching out to the western scientific community through attending meetings, publishing in scientific journals, etc is very important to address this problem. By not publishing more it is not only hurting China's growth but global growth as the opportunity to collaborate on research and find out about new discoveries is limited.
——Seth Goldenberg, President of Asia Pacific Bio Intelligence LLC
